Form 4 for GILD Gilead Sciences
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001638643-26-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-12 | 2026-03-10 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | +20.0K | 662.3K | +3% | — |
| D | 2026-03-12 | 2026-03-10 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | F - Tax | $148.56 | -9,767 | 652.6K | -1% | -$1.45M |
| DM | 2026-03-12 | 2026-03-10 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | A - Grant | $0.00 | +155.6K | 122.8K | New | $0 |
| D | 2026-03-12 | 2026-03-10 | GILD | O'Day Daniel Patrick | COB, CEO, Dir | M - OptEx | — | -20.0K | 68.0K | -23% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-10 | M | A | 20,026 | — | 662,334 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2026-03-10 | F | D | 9,767 | $148.56 | 652,567 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-03-10 | A | A | 32,815 | — | 100,859 | D | — · — to — | 32,815 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2026-03-10 | A | A | 122,755 | $0.00 | 122,755 | D | $148.56 · — to 2036-03-10 | 122,755 Common Stock | (F3) The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Restricted Stock Unit | 2026-03-10 | M | D | 20,026 | — | 68,044 | D | — · — to — | 20,026 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |